Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Home

Showing results (1-10 of 380) with videos related to

Pageof 38
Sort By:
Diabetologia|January 5, 2019
Cardiovascular outcome trials of glucose-lowering medications: an updatePhilip Home
Diabetes & Metabolism|May 15, 2003
The challenge of poorly controlled diabetes mellitusP Home
Expert Opinion on Investigational Drugs|July 5, 2005
Insulin glargine: the first clinically useful extended-acting insulin in half a century?P Home
Metabolism: Clinical and Experimental|September 18, 2021
Future directions in insulin therapyPhilip Home
Diabetes Technology & Therapeutics|June 2, 2012
Cardiovascular disease and oral agent glucose-lowering therapies in the management of type 2 diabetesPhilip Home
Diabetes Care|June 10, 2019
Controversies for Glucose Control Targets in Type 2 Diabetes: Exposing the Common GroundPhilip Home
Diabetes & Metabolism|April 4, 2000
[Is the regulation of prandial glucose important in type 2 diabetes?]P Home
Current Medical Research and Opinion|July 12, 2005
Contributions of basal and post-prandial hyperglycaemia to micro- and macrovascular complications in people with type 2 diabetesPhilip Home
The Journal of the Royal College of Physicians of Edinburgh|May 18, 2023
Insulin biobetters and biosimilars in clinical practicePhilip Home
Diabetes Research and Clinical Practice|April 16, 2021
The evolution of insulin therapyPhilip Home
Pageof 38

Showing results (1-10 of 380) with videos related to

Sort By:
Pageof 38
Diabetologia|January 5, 2019
Cardiovascular outcome trials of glucose-lowering medications: an updatePhilip Home
Diabetes & Metabolism|May 15, 2003
The challenge of poorly controlled diabetes mellitusP Home
Expert Opinion on Investigational Drugs|July 5, 2005
Insulin glargine: the first clinically useful extended-acting insulin in half a century?P Home
Metabolism: Clinical and Experimental|September 18, 2021
Future directions in insulin therapyPhilip Home
Diabetes Technology & Therapeutics|June 2, 2012
Cardiovascular disease and oral agent glucose-lowering therapies in the management of type 2 diabetesPhilip Home
Diabetes Care|June 10, 2019
Controversies for Glucose Control Targets in Type 2 Diabetes: Exposing the Common GroundPhilip Home
Diabetes & Metabolism|April 4, 2000
[Is the regulation of prandial glucose important in type 2 diabetes?]P Home
Current Medical Research and Opinion|July 12, 2005
Contributions of basal and post-prandial hyperglycaemia to micro- and macrovascular complications in people with type 2 diabetesPhilip Home
The Journal of the Royal College of Physicians of Edinburgh|May 18, 2023
Insulin biobetters and biosimilars in clinical practicePhilip Home
Diabetes Research and Clinical Practice|April 16, 2021
The evolution of insulin therapyPhilip Home
Pageof 38